Dr. Cheung Foon Yiu

Head of Clinical Oncology

MBChB(CUHK)

FRCR

FHKCR

FHKAM(Radiology)

Research & Publications

Law SCK, Cheung FY, Au SK, Chan DTM, Luk MY, Ng JWM, Lau WH. “ Early results of conventionally fractionated radiotherapy for Nasopharyngeal carcinoma” Oral presentation in 5th Hong Kong International Cancer Congress, Hong Kong 1998

Cheung FY, Au KH, Chan CL, Foo W. “Radiotherapy for Mycosis Fungoides in Chinese Patients” Journal of the Hong Kong College of Radiologists, Vol.3 Supplement 2000 p.273

Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B. Leung SF, Cheung FY, Yeo W, Yiu HH, Yu KH, Chiu KW, Chan DT, Mok T, Yuen KT, Mo F, Lai M, Kwan WH. “Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial” Journal of Clinical Oncology, 2002 Apr 15;20(8):1968-70

Fu YT, So PP, Cheung F. “Planned stereotatic radiotherapy boost for early T-stage nasopharyngeal carcinoma, experience of Queen Elizabeth Hospital, Hong Kong SAR, China” IJROBP 1 October 2002 Vol.54, Issue 2 (Supplement)

Ngan RK, Yiu HH, Lau WH, Yau S, Cheung FY, Chan TM, Kwok CH, Chiu CY, Au SK, Foo W, Law CK, Tse KC.“Combined gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study” Annual of Oncology 2002 Aug; 13(8):1252-8

So PF, Fu YT, Yau S, Cheung FY. “Stereotatic radiotherapy boost for nasopharyngeal carcinoma patient with persistent local disease after primary external radiotherapy, experience of Queen Elizabeth Hospital, Hong Kong SAR, China” IJROBP 1 October 2002 Vol.54 Issue 2 (Supplement)

Cheung FY, Leung KC, Chan PTM, Cheung MC, Cheng HC, Tong CC, Wong ISM, Ng JWM, FooW. “Radical Radiotherapy for Bladder Cancer, Queen Elizabeth Hospital Experience” Poster presentation and free paper presentation in 2nd Asia-Pacific Society of Uro-Oncology Meeting, Hong Kong 2003.

Cheung FY, So PF, Fu YT, Yau S, Lam J, Chan C. “Stereotatic Radiotherapy plus external radiotherapy as radical treatment in nasopharyngeal carcinoma with first local recurrence, Queen Elizabeth experience” European Journal of Cancer Supplements; Vol. 1, No.5 September 2003, p.S37

Chan AT, Ngan R, Teo P, Leung SF, Yiu HY, Yeo W, Mok T, Cheung FY, Kwan W, Zee B. “Final results of a phase III randomized study of concurrent weekly cisplatin-RT versus RT alone in locoregionally advanced nasopharyngeal carcinoma (NPC).” 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement).

Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TS, Yau S, Yuen KT, Mo FK, Lai MM, Ma BB, Kam MK, Leung TW, Johnson PJ, Choi PH, Zee BC “Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.” Journal of the National Cancer Institute 2005 April 6 97(7):536-9

Cheung FY, Leung KC, Cheung MC, Tong CC, Luk MY, Chan PTM, Sin VC, Ngan RKC “Favourable early outcome in 129 breast cancer patients with high risk node positive disease (N>3) after adjuvant sequential doxorubicin and CMF (Milan) regimen” Oral presentation in 13th Annual Scientific Meeting of Hong Kong College of radiologists and Joint Scientific Meeting of The Royal College of Radiologists & Hong Kong College of Radiologists 2005

Cheung FY, Leung KC, Luk MY, Tong CC, Chan TM, Sin VC, Cheung MC, Ngan KC. “Retrospective analysis of the clinical outcome of breast conservative treatment for Asian female breast cancer patients in a single institution in Hong Kong” Oral presentation in 13th Annual Scientific Meeting of Hong Kong College of radiologists and Joint Scientific Meeting of The Royal College of Radiologists & Hong Kong College of Radiologists 2005

Cheung FY, Tong CC, Sin VC, Chan TM, Cheung MC, Ngan KC. “The clinical outcome of 1034 Chinese patients after adjuvant therapies for female breast cancer, Hong Kong SAR, China” European Journal of Cancer Supplements Vol 3, No. 2 October 2005, p107

Cheung FY, Leung KC, Luk MY, Tong CC, Chan TM, Sin VC, Cheung MC, Ngan KC. “Retrospective analysis of the clinical outcome of breast conservative treatment for Asian female breast cancer patients in a single institution in Hong Kong” Oral presentation in The 6th Biennial Meeting of the Asian Breast Cancer Society 2007.

Leung KC, Cheung FY, Chan PTM, Cheung MC, Cheng HC, Tong CC, Wong ISM, Ng JWM, FooW. “Radical Radiotherapy for Bladder Cancer, Queen Elizabeth Hospital Experience” Oral presentation in 13th Annual Scientific Meeting of Hong Kong College of radiologists and Joint Scientific Meeting of The Royal College of Radiologists & Hong Kong College of Radiologists 2007

Chek W, Cheung FY, Lee KC, Chan J KC, “Cutaneous Indeterminate Cell Tumour with a protracted relapsing clinical course” American Journal of Surgical Pathology Vol33 No 8 August 2009, p1261

Cheung FY, Eva Liu, Francis Li, Charlie Chan, KH Wong, SK Au, KC Ngan, CK Law. “Early clinical outcome of simultaneous modulated accelerated radiation therapy (SMART) Image Guided Radiotherapy (IMRT) For Nasopharyngeal Carcinoma (NPC) in Queen Elizabeth Hospital (QEH), Hong Kong” European Journal of Cancer Supplements Vol 7, No 2 September 2009, p157

Yau T, Chan P, Cheung FY, Lee AS, Yau TK, Choo SP, Lau J, Wong JS, Fan ST, Poon RT. “Phase II Trial of Sorafenib with Capecitabine and Oxaliplatin (SECOX) in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma” European Journal of Cancer Supplements Vol 7 No 3 September 2009, p20

Cheung FY. “Review of the efficacy of bevacizumab in the treatment of metastatic breast cancer and its safety in Asian population” Poster presentation in 9th Roche Asian Oncology Forum, Indonesia 2010

Cheung FY, Ngan RKC. “Docetaxel chemotherapy for Chinese Castrate Resistant Prostate cancer patients, Queen Elizabeth Hospital Experience” Oral presentation in 16th Annual Scientific Meeting Hong Kong Urological Association 2010

Cheung FY, Mang OWK, Law SKC. “A population-based analysis of incidence, mortality and stage-specific survival of cervical cancer in Hong Kong: 1997-2006” Hong Kong Medical Journal 2010 in press

Tong CC, Au KH, Ngan RK, Chow SM, Cheung FY, Fu YT, Au JS, Law SC. “Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.” Radiation Oncology May 21 6, p53 2011

Cheung FY, Tong CC, Ngan RKC, “The clinical outcome of Chinese non-melanoma skin carcinoma patients after radiotherapy with megavoltage electron.” European Journal of Cancer Supplement 1 Vol 47 September 2011, pS656

Lee AS, Zee B, Cheung FY, Kwong P, Cheung A, Lai M, Kwok C, Jolivet J, Chiang CL, Leung KC, Siu S, Lee C, Tung Y. “Randomized Phase II study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma” Poster presentation in ASCO 2012

Tong CC, Au KH, Ngan RKC, Cheung FY, Chow SM, Fu YT, Au JSK, Law SCK. “Definitive Radiotherapy for early stage glottic cancer by 6MV photons” Head & Neck Oncology, 2012, 4:23

Cheung FY, Leung KC, Ngan EKC, “Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer” Hong Kong Med J 2013;19:237-41

Yau T, Cheung FY, Lee F, Choo SP, Wong H, Toh HC, Leung AK, Chan P, Yau TK, Wong J, Tang YF, Lau SM, Cheung TT, Fan ST, Poon TP, “ A Multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: Final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group Study.” J Clin Oncology 31, 2013 (suppl; abstr 4117)

Cheung FY, Hung AWM, Chan SHO, Ng WTA, “RapidArc for Head and Neck Cancer- PYNEH experience” Oral presentation in Varian Oncology Submit, ESTRO 2014

FST Mok, OSH Chan, ATY Chang, LLK Chan, IS Soong, WT Ng, FY Cheung, RMW Yeung ,Treatment Outcomes of Primary Pulmonary Lymphoepithelioma-like Carcinoma: a Series of 22 Patients and Treatment Strategy Review. Hong Kong J Radiol 2013 16:270-7

Ng WT, Lee MC, Chang AT, Chan OS, Chan LL, Cheung FY, Hung WM, Chan CC, Lee AW; The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT. Oral Oncol. 2014 May;50(5):506-12

Sze HC, Chan LL, Ng WT, Hung AW, Lee MC, Chang AT, Chan OS, Cheung FY, Yeung RM, Lee AW Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4? Oral Oncol. 2014 Dec;50(12):1188-95

Lee AS Francis, Zee CY Benny, Cheung FY, Kwong P, Chiang CL, Leung KC, Siu WK Steven, Lee Conrad, Lai Maria, Kwok Chloe, Chong M, Jolivet J, and Tung Steward. “Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma” Am J Clin Oncol 2014 online

Winnie Yeo, Hang-Mei Lee, Amy Chan, Emily YY Chan, Miranda CM Chan, Keeng-Wai Chan, Sharon WW Chan, Foon-Yiu Cheung, Polly SY Cheung, Peter HK Choi, Josette SY Chor, William WL Foo, Wing-Hong Kwan, Stephen CK Law, Lawrence PK Li, Janice WH Tsang, Yuk Tung, Lorna LS Wong, Ting-Ting Wong, Chun-Chung Yau, Tsz-Kok Yau, Benny CY Zee; “Risk factors and natural history of breast cancer in younger Chinese women” World Journal of Clinical Oncology December 10, 2014 Volume 5 Issue 5 p1097-1106

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, Silvia Falcon, Thomas Cosgriff, W. Graydon Harker,Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray Page,Sevil Bavbek, J. Thaddeus Beck, Poulam Patel, Foon-yiu Cheung, Sunil Yadav, Edward M. Schiff,Xufang Wang, Julie Niolat, Dalila Sellami, Oezlem Anak, and Jennifer J. Knox, “Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma” J Clin Oncology 2014 published online ahead of print

Lee Anne W.M., Ngan Roger K.C., Tung Stewart Y., Cheng Ashley; Kwong Dora L.W.; Lu Tai-Xiang , Chan Anthony T.C., Chan Lucy L.K., Yiu Harry, Ng Wai-Tong, Wong Frank, Yuen Kam-Tong, Yau Stephen, Cheung Foon-Yiu, Chan Oscar S.H., Choi Horace, and Rick Chappell, “ Preliminary Results of Trial NPC-0501 Evaluating the Therapeutic Gain by Changing From Concurrent-Adjuvant to Induction-Concurrent Chemoradiotherapy, Changing FromFluorouracil to Capecitabine, and Changing From Conventional to Accelerated Radiotherapy Fractionation in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma” Cancer 2014 online